Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex

Anna Jeong*, Jo Anne Nakagawa, Michael Wong

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Utilizing the multicenter TSC (tuberous sclerosis complex) Natural History Database including 2034 subjects, this study aimed to identify predictors of drug-resistant epilepsy in TSC. Basic epilepsy data were available for 1965 individuals in the database. Supplemental data were further collected from 1546 of these subjects through directed site queries, addressing additional epilepsy characteristics including the presence of drug-resistant epilepsy, therapies trialed, and outcomes of specific therapies. Epilepsy was reported in 86.4% of individuals with TSC. Infantile spasms were reported in 45.2% of individuals and focal seizures were reported in 84.4% of individuals. In those with focal epilepsy, drug resistance was reported in 59.6%, with focal seizure onset prior to age 1 year (odds ratio [OR] 1.9, confidence interval [CI] 1.4-2.5, P <.001), infantile spasms (OR 2.0, CI 1.5-2.5, P < 0.001), and infantile spasms incompletely responsive to therapy (OR 47.6, CI 6.7-333.3, P < 0.001) being associated with an increased likelihood of drug resistance.

Original languageEnglish (US)
Pages (from-to)1092-1098
Number of pages7
JournalJournal of child neurology
Volume32
Issue number14
DOIs
StatePublished - Dec 1 2017

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Grants from the National Institutes of Health (T32 NS007205 to Washington University, R01 NS056872 to MW) and the Missouri State Tuberous Sclerosis Fund.

Keywords

  • epilepsy
  • infantile spasms
  • refractory
  • seizures
  • tuberous sclerosis complex

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Predictors of Drug-Resistant Epilepsy in Tuberous Sclerosis Complex'. Together they form a unique fingerprint.

Cite this